Natixis Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6M Sell
377,872
-15,998
-4% -$1.4M 0.04% 397
2026
Q1
$33.6M Buy
393,870
+39,671
+11% +$3.54M 0.05% 369
2025
Q4
$28M Buy
354,199
+38,548
+12% +$3.02M 0.04% 394
2025
Q3
$25.2M Sell
315,651
-69,383
-18% -$5.92M 0.04% 414
2025
Q2
$35M Buy
385,034
+26,471
+7% +$2.42M 0.06% 318
2025
Q1
$33.6M Buy
358,563
+52,538
+17% +$4.7M 0.06% 305
2024
Q4
$27.8M Sell
306,025
-80,656
-21% -$7.7M 0.05% 340
2024
Q3
$40.1M Buy
386,681
+51,991
+16% +$5.3M 0.08% 262
2024
Q2
$32.5M Buy
334,690
+102,083
+44% +$9.42M 0.07% 275
2024
Q1
$20.9M Buy
232,607
+32,622
+16% +$2.76M 0.05% 383
2023
Q4
$15.9M Buy
199,985
+44,122
+28% +$3.32M 0.04% 422
2023
Q3
$11.1M Sell
155,863
-6,184
-4% -$462K 0.03% 484
2023
Q2
$12.5M Buy
162,047
+30,945
+24% +$2.4M 0.04% 457
2023
Q1
$9.85M Sell
131,102
-49,126
-27% -$3.65M 0.03% 491
2022
Q4
$14.2M Sell
180,228
-1,341
-0.7% -$101K 0.05% 376
2022
Q3
$12.8M Sell
181,569
-205,187
-53% -$16.1M 0.05% 374
2022
Q2
$31M Buy
386,756
+70,104
+22% +$5.48M 0.14% 175
2022
Q1
$24M Sell
316,652
-571,469
-64% -$45.3M 0.09% 244
2021
Q4
$75.8M Sell
888,121
-218,586
-20% -$17.1M 0.29% 78
2021
Q3
$83.6M Buy
1,106,707
+390,172
+54% +$31M 0.34% 56
2021
Q2
$58.3M Buy
716,535
+73,271
+11% +$5.99M 0.27% 83
2021
Q1
$50.7M Buy
643,264
+120,752
+23% +$9.46M 0.26% 84
2020
Q4
$44.7M Sell
522,512
-171,932
-25% -$14.2M 0.26% 83
2020
Q3
$53.6M Sell
694,444
-25,691
-4% -$1.96M 0.34% 60
2020
Q2
$52.8M Buy
720,135
+19,970
+3% +$1.42M 0.35% 56
2020
Q1
$46.5M Buy
700,165
+41,143
+6% +$2.9M 0.38% 55
2019
Q4
$45.4M Sell
659,022
-58,588
-8% -$3.99M 0.32% 64
2019
Q3
$52.8M Sell
717,610
-36,973
-5% -$2.68M 0.42% 53
2019
Q2
$54.1M Buy
754,583
+2,100
+0.3% +$149K 0.44% 50
2019
Q1
$51.6M Buy
752,483
+105,271
+16% +$6.8M 0.45% 48
2018
Q4
$38.5M Sell
647,212
-67,903
-9% -$4.25M 0.38% 56
2018
Q3
$47.9M Buy
715,115
+55,761
+8% +$3.71M 0.42% 47
2018
Q2
$42.7M Buy
659,354
+593,518
+902% +$38.8M 0.41% 46
2018
Q1
$4.72M Buy
65,836
+30,174
+85% +$2.17M 0.05% 461
2017
Q4
$2.69M Sell
35,662
-86,900
-71% -$6.35M 0.03% 620
2017
Q3
$8.93M Buy
122,562
+10,110
+9% +$729K 0.09% 248
2017
Q2
$8.34M Buy
112,452
+1,561
+1% +$116K 0.09% 264
2017
Q1
$8.12M Buy
110,891
+7,778
+8% +$544K 0.09% 262
2016
Q4
$6.75M Buy
103,113
+13,157
+15% +$902K 0.08% 309
2016
Q3
$6.67M Buy
89,956
+782
+0.9% +$57.8K 0.09% 287
2016
Q2
$6.53M Buy
89,174
+2,970
+3% +$211K 0.09% 284
2016
Q1
$6.09M Buy
86,204
+6,023
+8% +$401K 0.09% 273
2015
Q4
$5.34M Buy
80,181
+8,085
+11% +$538K 0.09% 302
2015
Q3
$4.58M Sell
72,096
-15,245
-17% -$996K 0.08% 346
2015
Q2
$5.71M Buy
87,341
+5,458
+7% +$370K 0.1% 289
2015
Q1
$5.68M Sell
81,883
-12,646
-13% -$874K 0.1% 304
2014
Q4
$6.54M Buy
94,529
+11,594
+14% +$783K 0.12% 243
2014
Q3
$5.41M Buy
82,935
+4,707
+6% +$310K 0.11% 283
2014
Q2
$5.33M Buy
78,228
+2,168
+3% +$145K 0.08% 418
2014
Q1
$4.93M Buy
76,060
+8,154
+12% +$514K 0.08% 416
2013
Q4
$4.43M Buy
67,906
+6,385
+10% +$409K 0.07% 427
2013
Q3
$3.65M Buy
61,521
+7,400
+14% +$438K 0.07% 440
2013
Q2
$3.1M Buy
+54,121
New +$3.21M 0.06% 469

Other funds holding CL

Natixis Advisors's CL Position: Q2 2026 in Review

Natixis Advisors reduced its Colgate-Palmolive (CL) stake by 4.1% in Q2 2026, selling an estimated $1.4M and leaving 377,872 shares worth $34.6M. The position accounts for 0.04% of the portfolio, ranked #397.

Natixis Advisors first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $83.6M in Q3 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Natixis Advisors held 377,872 shares of Colgate-Palmolive worth $34.6M as of Q2 2026.
  • Natixis Advisors sold 15,998 Colgate-Palmolive shares in Q2 2026, an estimated $1.4M.
  • Colgate-Palmolive made up 0.04% of Natixis Advisors's portfolio in Q2 2026, its #397 holding.
  • Natixis Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Colgate-Palmolive position peaked at $83.6M in Q3 2021.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.